UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3197) 3197
Book Chapter (30) 30
Newsletter (13) 13
Magazine Article (9) 9
Book / eBook (5) 5
Conference Proceeding (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2998) 2998
science & technology (2062) 2062
life sciences & biomedicine (2009) 2009
female (1678) 1678
male (1618) 1618
middle aged (1429) 1429
aged (1222) 1222
oncology (1180) 1180
pleural neoplasms - drug therapy (1144) 1144
adult (937) 937
mesothelioma - drug therapy (914) 914
mesothelioma (708) 708
antineoplastic combined chemotherapy protocols - therapeutic use (614) 614
pleural neoplasms - pathology (605) 605
lung neoplasms - drug therapy (583) 583
treatment outcome (543) 543
mesothelioma - pathology (535) 535
respiratory system (532) 532
chemotherapy (489) 489
cancer (442) 442
antineoplastic agents - therapeutic use (401) 401
prognosis (392) 392
lung neoplasms - pathology (388) 388
abridged index medicus (386) 386
aged, 80 and over (376) 376
care and treatment (327) 327
cisplatin - administration & dosage (327) 327
pleural effusion (322) 322
lung cancer (318) 318
animals (314) 314
combined modality therapy (311) 311
malignant pleural mesothelioma (296) 296
surgery (286) 286
cell line, tumor (281) 281
pleural neoplasms - therapy (258) 258
retrospective studies (253) 253
pleural neoplasms - surgery (252) 252
pleural neoplasms - mortality (249) 249
mesothelioma - mortality (248) 248
pleural effusion, malignant - drug therapy (245) 245
pleural effusion - etiology (243) 243
pemetrexed (236) 236
neoplasm staging (234) 234
tumors (234) 234
tomography, x-ray computed (233) 233
survival rate (227) 227
mesothelioma - therapy (222) 222
pleural neoplasms - secondary (214) 214
pleural neoplasms - metabolism (209) 209
mesothelioma - metabolism (208) 208
general & internal medicine (205) 205
mesothelioma - surgery (202) 202
mice (202) 202
pleural neoplasms - diagnosis (200) 200
analysis (195) 195
research (192) 192
guanine - analogs & derivatives (191) 191
medicine & public health (187) 187
pleural effusion, malignant - pathology (185) 185
health aspects (184) 184
patients (177) 177
diagnosis (172) 172
follow-up studies (172) 172
pleural effusion - drug therapy (170) 170
pleural neoplasms - genetics (166) 166
survival analysis (166) 166
mesothelioma - genetics (165) 165
metastasis (165) 165
pleural effusion, malignant - etiology (165) 165
pleural effusions (165) 165
antineoplastic agents - administration & dosage (164) 164
lung neoplasms - complications (164) 164
hematology, oncology and palliative medicine (155) 155
immunohistochemistry (155) 155
lung neoplasms - genetics (153) 153
mesothelioma - diagnosis (153) 153
pathology (146) 146
biopsy (141) 141
diagnosis, differential (141) 141
cancer therapies (140) 140
antineoplastic agents - pharmacology (139) 139
carcinoma, non-small-cell lung - drug therapy (138) 138
lung neoplasms - metabolism (137) 137
time factors (135) 135
adenocarcinoma - drug therapy (133) 133
cisplatin (132) 132
lung neoplasms - diagnosis (132) 132
pleura (131) 131
antineoplastic combined chemotherapy protocols - adverse effects (128) 128
medicine, general & internal (126) 126
apoptosis (125) 125
risk factors (122) 122
lung neoplasms - therapy (121) 121
fatal outcome (120) 120
drug administration schedule (119) 119
malignant pleural effusion (119) 119
breast neoplasms - drug therapy (118) 118
medical prognosis (118) 118
disease-free survival (117) 117
glutamates - administration & dosage (117) 117
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2909) 2909
Japanese (156) 156
French (88) 88
German (75) 75
Italian (23) 23
Spanish (22) 22
Chinese (19) 19
Russian (18) 18
Polish (15) 15
Dutch (3) 3
Hungarian (3) 3
Romanian (3) 3
Danish (2) 2
Norwegian (2) 2
Portuguese (2) 2
Croatian (1) 1
Czech (1) 1
Hebrew (1) 1
Lithuanian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British journal of cancer, ISSN 0007-0920, 01/2010, Volume 102, Issue 1, pp. 220 - 226
Journal Article
European journal of endocrinology, ISSN 0804-4643, 2014, Volume 170, Issue 4, pp. 575 - 582
Journal Article
Clinical cancer research, ISSN 1557-3265, 10/2006, Volume 12, Issue 19, pp. 5777 - 5785
... of chromatin remodeling agents for cancer therapy. A phase I trial was done to examine pharmacokinetics, toxicities, and gene expression mediated by 5-aza-2′-deoxycytidine (DAC... 
lung cancer | clinical trial | esophageal cancer | mesothelioma | epigenetics | 5-aza-2′-deoxycytidine | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Genes, p16 - physiology | Pleural Neoplasms - genetics | DNA Modification Methylases - antagonists & inhibitors | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Humans | Lung Neoplasms - metabolism | Middle Aged | Transcriptional Activation | Male | Neoplasm Proteins - metabolism | Pleural Neoplasms - drug therapy | Pleural Neoplasms - metabolism | Esophageal Neoplasms - metabolism | Antigens, Neoplasm - metabolism | Adult | Antimetabolites, Antineoplastic - pharmacology | Female | Membrane Proteins - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Neoplasm Proteins - genetics | Lung Neoplasms - genetics | Antigens, Neoplasm - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Membrane Proteins - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Azacitidine - analogs & derivatives | Mesothelioma - genetics | Mesothelioma - drug therapy | Azacitidine - pharmacology | Maximum Tolerated Dose | Carcinoma, Squamous Cell - drug therapy | Mesothelioma - metabolism | Esophageal Neoplasms - genetics | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Esophageal Neoplasms - drug therapy | Index Medicus
Journal Article
Clinical cancer research, ISSN 1557-3265, 06/2017, Volume 23, Issue 12, pp. 3191 - 3202
Purpose: To better define malignant pleural mesothelioma (MPM) heterogeneity and identify molecular subtypes of MPM, we focus on the tumor suppressor gene... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Pleural Neoplasms - genetics | Mesothelioma - pathology | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Cell Survival - genetics | Apoptosis - genetics | Lung Neoplasms - pathology | Male | Pleural Neoplasms - drug therapy | TOR Serine-Threonine Kinases - antagonists & inhibitors | Pyridones - administration & dosage | Neoplasm Invasiveness - pathology | Tumor Suppressor Proteins - genetics | Aged, 80 and over | Adult | Female | Genes, Tumor Suppressor | Pleural Neoplasms - pathology | Lung Neoplasms - genetics | Cell Proliferation - genetics | Pyrimidines - administration & dosage | Protein-Serine-Threonine Kinases - genetics | Mesothelioma - genetics | Neurofibromatosis 2 - genetics | Mesothelioma - drug therapy | Aged | Mutation | Neoplasm Invasiveness - genetics | TOR protein | Cell proliferation | Contact inhibition | Phosphorylation | Genes | Neurofibromin 2 | Mesothelioma | AKT protein | Inactivation | Carcinogenesis | Signal transduction | Carcinogens | Deactivation | Rapamycin | siRNA | 1-Phosphatidylinositol 3-kinase | Polymerase chain reaction | Yes-associated protein | Signaling | Sensitivity | Protein arrays | Inhibitors | Experimental design | Biomarkers | Tumor suppressor genes | Viability | Cancer | Apoptosis | Index Medicus | Cell Proliferation | Protein-Serine-Threonine Kinases | Genomics | Neurofibromatosis 2 | Cellular Biology | Lung Neoplasms | Life Sciences | Pyrimidines | Genetics | Pleural Neoplasms | Neoplasm Invasiveness | Cell Survival | Biochemistry, Molecular Biology | Pyridones | TOR Serine-Threonine Kinases | Molecular biology | Tumor Suppressor Proteins | Human genetics
Journal Article
Cancer biology & therapy, ISSN 1555-8576, 02/2018, Volume 19, Issue 4, pp. 316 - 327
Journal Article
The lancet oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1386 - 1396
Journal Article
Nature communications, ISSN 2041-1723, 03/2019, Volume 10, Issue 1, pp. 1333 - 1333
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2017, Volume 76, pp. 84 - 92
Abstract Background Preclinical models that mimic pathological and molecular features of solitary fibrous tumour (SFT) represent an important tool to select... 
Hematology, Oncology and Palliative Medicine | Eribulin | Xenograft | Sarcoma | Ifosfamide | Mice model | Solitary fibrous tumour | Metastasis | Trabectedin | Doxorubicin | Dacarbazine | Chemotherapy | Treatment | Anthracycline | Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Soft Tissue Neoplasms - drug therapy | Male | Response Evaluation Criteria in Solid Tumors | Pleural Neoplasms - drug therapy | Retroperitoneal Neoplasms - mortality | Meningeal Neoplasms - drug therapy | Retroperitoneal Neoplasms - drug therapy | Dioxoles - administration & dosage | Adult | Female | Retrospective Studies | Doxorubicin - administration & dosage | Cerebellar Neoplasms - drug therapy | Dacarbazine - administration & dosage | Soft Tissue Neoplasms - mortality | Solitary Fibrous Tumors - drug therapy | Solitary Fibrous Tumors - mortality | Cerebellar Neoplasms - mortality | Ketones - administration & dosage | Survival Rate | Tetrahydroisoquinolines - administration & dosage | Pleural Neoplasms - mortality | Kidney Neoplasms - mortality | Mice, SCID | Blotting, Western | Meningeal Neoplasms - mortality | Xenograft Model Antitumor Assays | Disease-Free Survival | Animals | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Kidney Neoplasms - drug therapy | Furans - administration & dosage | Analysis | Melanoma | Stem cells | Anthracyclines | Cancer | Drugs | Animal models | Progressions | Xenotransplantation | Immunodeficiency | Clinical trials | Patients | Survival | Anticancer properties | Studies | Molecular modelling | Xenografts | Mice | In vivo methods and tests | Mathematical models | Drug therapy | Tumors | Index Medicus
Journal Article
European radiology, ISSN 0938-7994, 07/2007, Volume 17, Issue 7, pp. 1700 - 1713
.... Thirteen patients were examined just before and every 4-6 weeks after starting therapy. Following intravenous injection of a contrast agent, dynamic image acquisition was obtained at the level of a selected tumor location... 
Computed tomography | Radiology Nuclear Medicine and imaging | Perfusion | Neoplasms | Medicine & Public Health | Diagnostic Radiology | Internal Medicine | Interventional Radiology | Imaging / Radiology | Ultrasound | Neuroradiology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Injections, Intravenous | Prognosis | Angiography | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Tomography, Spiral Computed | Pleural Neoplasms - drug therapy | Dose-Response Relationship, Drug | Pancreatic Neoplasms - drug therapy | Mediastinal Neoplasms - drug therapy | Pleural Neoplasms - diagnostic imaging | Contrast Media - administration & dosage | Pelvic Neoplasms - drug therapy | Adult | Female | Quinazolines - administration & dosage | Gefitinib | Liver Neoplasms - secondary | Administration, Oral | Liver Neoplasms - drug therapy | Mediastinal Neoplasms - diagnostic imaging | Pelvic Neoplasms - diagnostic imaging | Liver Neoplasms - diagnostic imaging | Disease Progression | Image Processing, Computer-Assisted | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quinazolines - adverse effects | Aged | Pancreatic Neoplasms - diagnostic imaging | CT imaging | Usage | Care and treatment | Analysis | Cancer | Index Medicus
Journal Article